Skip to main content
. 2012 Jan;167(1):15–25. doi: 10.1111/j.1365-2249.2011.04469.x

Table 1.

Cell surface markers showing abnormal expression on B cells after haematopoietic stem cell transplantation (HSCT)

Antigen Number of cells* Comments References
mIgM A High levels of membrane bound IgM on B cells post-HSCT [98100]
mIgD A Slightly increased levels of membrane-bound IgD post-HSCT [98]
Few mIgD- class-switched cells 1 year after transplantation [21]
CD1c + Increased numbers first year post-HSCT [97]
CD5 + Increased numbers first year post-HSCT [9698,101]
Increased expression of IgM, CD20 and HLA-DR on CD5+ B cells [101]
Normal expression of CD11a, CD44, CD54 and CD62L on CD5+ B cells [102]
N Normal numbers first year post-HSCT [103]
CD10 + Increased numbers post-HSCT [95,104,105]
N Normal numbers post-HSCT [97,103,106]
CD11a Decreased numbers of CD5- B cells that express CD11a 4 months after transplantation [102]
CD21 Decreased numbers first half-year post-GSCT [27,93,98,99,105]
N Normal numbers of cells first 10 months post-HSCT [97,103]
CD23 Low numbers first half-year post-HSCT, then normal or slightly increased numbers of cells [26]
+ Increased numbers of cells first 10 months, then normal numbers [97,103,104]
N Normal numbers early and late post-HSCT [98]
CD27 Low numbers post-HSCT. Both IgM+ and class-switched cells affected [20,9194]
CD38 + Increased numbers first half-year post-HSCT [9799,106]
CD44 Low numbers of CD5- B cells that express CD44 4 months after transplantation [102]
CD54 Low numbers of CD5- B cells that express CD54 4 months after transplantation [102]
CD62L Low numbers first 10 months [98,103]
Low numbers of CD5- B cells express CD62L 4 months after transplantation [102]
N Normal numbers post-HSCT [97]
HLA-DR N Normal numbers post-HSCT [97,106]
*

The number of B cells in blood expressing the respective marker: A: all B cells; N: normal expression compared to healthy controls; −: decreased percentage of B cells in blood compared to healthy control; +: increased percentage of B cells in blood compared to healthy control; HLA-DR: human leucocyte antigen D-relayed; Ig: immunoglobulin.